Kionex (Sodium Polystyrene Sulfonate Suspension) and Moxetumomab pasudotox
Determining the interaction of Kionex (Sodium Polystyrene Sulfonate Suspension) and Moxetumomab pasudotox and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: sodium polystyrene sulfonate
Brand name: Kalexate, Kayexalate, Kionex
Synonyms: Kionex
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Kionex (Sodium Polystyrene Sulfonate Suspension)-Moxetumomab Pasudotox-tdfk
- Kionex (Sodium Polystyrene Sulfonate Suspension)-Moxetumomab pasudotox-tdfk Intravenous
- Kionex (Sodium Polystyrene Sulfonate Suspension)-Moxifloxacin
- Kionex (Sodium Polystyrene Sulfonate Suspension)-Moxifloxacin (Systemic)
- Kionex (Sodium Polystyrene Sulfonate Suspension)-Moxifloxacin Hydrochloride
- Kionex (Sodium Polystyrene Sulfonate Suspension)-Moxifloxacin Injection
- Moxetumomab pasudotox-Kirkland Signature Sleep Aid
- Moxetumomab pasudotox-Kirklands Childrens Aller-Tec
- Moxetumomab pasudotox-Kirklands Signature Aller-Tec
- Moxetumomab pasudotox-Kisqali
- Moxetumomab pasudotox-Kisqali (200 MG Dose)
- Moxetumomab pasudotox-Kisqali (400 MG Dose)